Alvotech REYKJAVIK, Iceland, July 11, 2024 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a orbicular biotech consort specializing in the utilization and concoct of biosimilar medicines for patients worldwide, today declared the approaching of its previously declared grownup secured prototypal lien constituent give artefact (the “Facility”). The approaching has allowed Alvotech to refinance unpaid debt obligations, …

Read More